Nexus Dx Rolls Up ITC
San Diego-based Nexus Dx, a startup founded in 2009 to consolidate technologies focused on point of care blood diagnostic testing, said yesterday it has merged with New Jersey-based International Technidyne Corp. (ITC). The New Jersey company specializes in hemostasis management (the process in which bleeding stops). The private equity firm Warburg Pincus acquired ITC for $55 million immediately prior to the merger. ITC was previously a subsidiary of Pleasanton, CA-based Thoratec (NASDAQ: THOR).